Search clinical trials for: Dopamine Agonists

Total 16835 results

GlaxoSmithKline

Completed

A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

Restless Legs Syndrome

United States
UCB Pharma

Terminated

Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction (ROADMAP)

Advanced Parkinson's Disease

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition

Healthy

India
University of British Columbia
Rick Hansen Institute

Completed

The Canadian Multicentre CSF Monitoring and Biomarker Study (CAMPER)

Spinal Cord Injury

Canada, United States
Otsuka Pharmaceutical Co., Ltd.

Recruiting

Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia

Schizophrenia

Japan
Luye Pharma Group Ltd.

Completed

A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro

Parkinson Disease

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Nervous System Diseases | Alzheimer's Disease | Mental Disorder | Agitation Associated With | Alzheimer's Type

France, United States, Bulgaria, Slovenia, United Kingdom, Russian Federation, Ukraine, Finland, Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions

To Determine Bioequivalence Under Fed Conditions

Canada
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia

Schizophrenia

United States
John Winkelman, MD, PhD
UCB Pharma

Completed

Switching From Oral Dopamine Agonists to Rotigotine (SWITCH)

Restless Legs Syndrome | Ekbom Syndrome | Willis-Ekbom Disease

United States
GlaxoSmithKline

Completed

Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole

Parkinson Disease

Germany, South Africa
Otsuka Pharmaceutical Development & Commercialization...

Completed

PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients

Parkinson's Disease

Japan
GlaxoSmithKline

Completed

The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

Restless Legs Syndrome | Moderate to Severe Idiopathic Restless Legs Syndrome (RLS)

Germany
Federico II University

Completed

Cardiac Valve Complications in Prolactinomas Treated With Cabergoline (ValveCab)

Prolactinomas

Italy
Sheba Medical Center
Jerusalem Mental Health Center

Unknown

A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.

Bipolar Disorder | Major Depressive Disorder

Israel
Seoul National University Hospital

Recruiting

Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

Pituitary Adenoma | Pituitary Tumor | Prolactinoma | Recurrence Tumor

Korea, Republic of
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type

Alzheimer Dementia | Agitation Associated With Alzheimer's Dementia

United States
Peking University Third Hospital

Completed

Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease

Parkinson's Disease

China
GlaxoSmithKline

Completed

Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa

Parkinson Disease

United States, France, Spain, Poland, Belgium, Hungary, Germany, Italy, Czech Republic
Columbia University

Completed

Effect of Cabergoline on Weight and Glucose Tolerance

Body Weight | Impaired Glucose Tolerance in Obese

United States
University of Virginia
National Institutes of Health (NIH)

Unknown

Effect of Gene Variants on Dopamine Receptor Natriuretic Responses

Hypertension

United States
Mashhad University of Medical Sciences

Unknown

Cabergoline Effect on Blood Sugar in Type 2 Diabetics

Diabetes Type 2
Pfizer

Completed

A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS

Restless Legs Syndrome
Hospital Clinic of Barcelona

Completed

Terlipressin in Septic Shock in Cirrhosis

Liver Cirrhosis | Septic Shock

Spain
Veterans Medical Research Foundation
National Institute of Mental Health (NIMH)

Completed

Side Effects of Newer Antipsychotics in Older Adults

Schizophrenia | Dementia | Alzheimer's Disease

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia

Schizophrenia
Otsuka Pharmaceutical Development & Commercialization...

Completed

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia (ASPIRE)

Schizophrenia

Korea, Republic of, United States, Estonia, Italy, Hungary, Bulgaria, Croatia, France, Poland, Thailand, Puerto Rico, Chile, South Africa, Austria, Belgium
Pfizer

Completed

Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects

Pharmacokinetics | Cytochrome P-450 CYP2D6 | CYP3A4 Protein, Human

United States
Mount Sinai Hospital, Canada
The Hospital for Sick Children; Sunnybrook Health Sciences Centre; University... and other collaborators

Recruiting

Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis

Late-Onset Neonatal Sepsis | Neonatal Hypotension | Extreme Prematurity

Canada, United States, Ireland, Israel
Tampere University Hospital

Completed

The Effect of Norepinephrine and Dopamine on Radial Forearm Free Flap Tissue Oxygen Pressure and Microdialysate Metabolite Measurements

Head and Neck Cancer

Finland
Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

Prolactinoma | Hyperprolactinemia

United States
Fertility Center of Las Vegas

Completed

Cabergoline Before or After Oocyte Collection for Follicular Resolution

Infertility, Female

United States
Sandoz

Terminated

An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine.

Parkinson Disease

Germany
GlaxoSmithKline

Completed

A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda

Parkinson Disease

Belgium
University of Aarhus
Aarhus University Hospital

Withdrawn

Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment

Insulin Resistance | Hyperprolactinemia

Denmark
H. Lundbeck A/S

Completed

Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy

Irritability | Major Depressive Disorder

United States
UCB Pharma
Otsuka Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects

Healthy Volunteers

Germany
Bambino Gesù Hospital and Research Institute

Completed

Fenoldopam in Pediatric Cardiac Surgery

Kidney Failure, Acute

Italy
Faculdade de Medicina de Valenca

Completed

Tinnitus Treatment With Piribedil Guided by Acoustic Otoemissions and Electrocochleography (piribedil)

Tinnitus

Brazil
Otsuka Pharmaceutical Development & Commercialization...

Terminated

To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States, Australia, Bulgaria, Romania, India, Slovakia, Philippines
University of California, San Francisco
The Dana Foundation

Terminated

Antipsychotic Effects on Brain Function in Schizophrenia (APD)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

United States
Indiana University
National Institute of Mental Health (NIMH)

Completed

Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism

Autistic Disorder

United States
Tianjin Medical University General Hospital
Shanghai Mental Health Center; Nanjing Medical University; First Affiliated Hospital... and other collaborators

Unknown

Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals

Schizophrenia | Anxiety Disorders | Major Depressive Disorder

China
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

Finland, Germany, Korea, Republic of, United States, Taiwan, Estonia, India, Italy, Mexico
University Health Network, Toronto
University of British Columbia; McGill University; Centre for Addiction and Mental... and other collaborators

Completed

Canadian Biomarker Integration Network for Depression Study (CAN-BIND-1)

Major Depressive Disorder

Canada
Centre Hospitalier Universitaire de Nice

Completed

Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic

Schizophrenia | Dissociative Disorders

France
Washington University School of Medicine
Pfizer

Withdrawn

Metabolic Effects of Antipsychotic Substitution in Children (SMEAC)

Diabetes
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa

Eating Disorders

United States, Canada

Search clinical trials for: Dopamine Agonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations